{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-070028","form_type":"8-K","ticker":"RBOT","cik":"0001812173","company_name":"Vicarious Surgical Inc.","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.076869+00:00","generated_at":"2026-05-17T22:25:34.447064+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Vicarious Surgical appoints Stephen From as CEO, Adam Sachs becomes President","bullets":["Stephen From appointed CEO effective Aug 7, 2025; also joins Board.","Co-founder Adam Sachs transitions from CEO to President, remains on Board.","From receives $500k base salary, 50% target bonus, and 297,600-share option grant.","From previously CEO of Aruna Bio and Kiora Pharmaceuticals; 20+ yrs healthcare leadership."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-070028","json":"https://secwatch.observer/filing/0001213900-25-070028.json","markdown":"https://secwatch.observer/filing/0001213900-25-070028.md","text":"https://secwatch.observer/filing/0001213900-25-070028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812173/000121390025070028/0001213900-25-070028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812173/000121390025070028/ea0251051-8k_vicarious.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:25:34.447064+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}